When Lyme Disease Treatment Guidelines Don’t Work: PTLDS and Clinical Decisions
What happens when Lyme disease guidelines don’t fit?
How should clinicians approach persistent symptoms?
Ethics and uncertainty shape real-world decisions.
Lyme disease treatment guidelines provide structure for care, but post-treatment Lyme disease syndrome (PTLDS) guidelines do not always account for every clinical scenario. When symptoms persist or testing does not align with the patient’s condition, clinicians must balance guidelines with clinical judgment.
This creates a central ethical question: what is the right course of care when standard recommendations do not resolve patient symptoms?
When Lyme Disease Treatment Guidelines Fall Short
Standard treatment guidelines are based on population-level data. However, individual patients may not follow expected recovery patterns.
In post-treatment Lyme disease syndrome (PTLDS), patients may continue to experience fatigue, pain, and cognitive symptoms after completing recommended antibiotic therapy.
This can leave both clinicians and patients facing uncertainty.
Start here: Post-treatment Lyme disease syndrome (PTLDS)
Prolonged Antibiotics and Clinical Controversy
One of the most debated areas in Lyme disease care is whether prolonged antibiotics for Lyme disease are appropriate for persistent symptoms.
Some guidelines do not recommend extended antibiotic treatment, citing limited evidence of benefit in clinical trials. However, patient experiences and clinical observations may not always align with these recommendations.
This tension reflects a broader ethical challenge: how to apply population-based evidence to individual patients.
Diagnostic Uncertainty in Lyme Disease
Lyme disease testing has known limitations. Antibody-based tests may be negative early in infection or may not fully capture complex or persistent illness.
This uncertainty complicates treatment decisions and can lead to differing interpretations of the same clinical picture.
Ethical care requires acknowledging these limitations rather than overstating diagnostic certainty.
Related: Lyme test accuracy
Balancing Guidelines with Individual Care
Ethical treatment decisions require integrating guidelines with patient-specific factors:
- Symptom persistence and severity
- Exposure history
- Response to prior treatment
- Potential co-infections
- Functional impact on daily life
The goal is not to reject guidelines, but to apply them thoughtfully and adapt when necessary.
Respecting Patient Experience in PTLDS
Patients with PTLDS often report ongoing symptoms such as fatigue, cognitive dysfunction, and pain.
These symptoms may not always be explained by standard models of infection, but they are clinically significant.
Listening carefully to patient experience is an essential part of ethical care.
Are Prolonged Antibiotics Recommended for PTLDS?
Most treatment guidelines do not recommend prolonged antibiotics for post-treatment Lyme disease syndrome (PTLDS), citing limited evidence of benefit in clinical trials. However, treatment decisions may vary based on individual patient factors, symptom severity, and clinical judgment.
Clinical Takeaway
Lyme disease treatment guidelines provide structure—but not certainty.
Ethical care requires balancing evidence, clinical judgment, and patient experience, particularly in complex cases such as PTLDS.
In uncertain conditions, careful reasoning and continued evaluation are essential.
Related: Recovery from Lyme disease
About the Author
Reviewed and authored by Daniel Cameron, MD, MPH
Dr. Cameron is a board-certified physician specializing in Lyme disease and tick-borne illnesses. He is a past president of the International Lyme and Associated Diseases Society (ILADS) and has contributed to national discussions on diagnostic limitations and patient-centered care.
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
In regard to your FAQ,s above (#1), why will you not move beyond ILADS treatment protocols and treat me with the Dapsone protocol that has shown to be effective with years long remissions? Have you forgotten that you once started with experimentation on patients 37 years ago to arrive at your published protocols that are good, but do not work for all patients?
I understand the frustration behind this question. Lyme disease can be complex, and not every approach works for every patient. My treatment decisions are guided by patient safety, clinical experience, and the best available evidence at this time. I continue to follow the research as it evolves.
As the saying goes, “nurse, heal thyself”. And I will, I have the means to do so. Too bad I have to go it alone.